SCHEMBL19785448

SCHEMBL19785448

N#CB1CCC(C#N)(c2cccnc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.39
▸ TNF P01375 1/20 0.35
▸ OPRD1 P41143 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ CCR1 P32246 1/20 0.33
▸ VNN1 O95497 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ CHRM5 P08912 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ RIN1 Q13671 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20558279 0.85 HSD11B1 (0.44) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL30373977 0.82 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL625012 0.82 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL55992 0.82 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL30467212 0.82 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL15822378 0.81 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL3644735 0.81 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL31441137 0.81 HSD11B1 (0.42) HSD11B1TNFOPRD1OPRM1CCR1
SCHEMBL21287848 0.80 OPRM1 (0.49) OPRD1OPRM1ALDH1A1CA12CA1
SCHEMBL14542590 0.78 HSD11B1 (0.40) HSD11B1TNFOPRD1OPRM1CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484856-B1 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS REVOLUTION MEDICINES INC (US) 2023-11-15 — — EP disclosed
WO-2018013597-A1 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS Revolution Medicines, Inc. (US) 2018-01-18 — — WO disclosed
Send feedback